Day: October 1, 2021

Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing

Written by Customer Service on October 1, 2021. Posted in Mergers And Acquisitions.

Roivant will begin trading on Nasdaq under the ticker “ROIV” later today R&D Day presentations from September 28th highlighting Roivant’s pipeline and discovery platform available on Roivant’s investor pageBASEL, Switzerland and LONDON and NEW YORK and BOSTON, Oct. 01, 2021 (GLOBE NEWSWIRE) — Roivant Sciences, a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it has closed its business combination with Montes Archimedes Acquisition Corp. (Nasdaq: MAAC), a special purpose acquisition company, as well as a concurrent PIPE financing. Outstanding shares and warrants of MAAC have been exchanged for newly issued Roivant shares and warrants, which will begin trading on Nasdaq under the ticker symbols “ROIV” and “ROIVW” later today. At the close of this transaction...

Farmers & Merchants Bancorp, Inc. Announces Completion of the Perpetual Federal Savings Bank Acquisition

Written by Customer Service on October 1, 2021. Posted in Mergers And Acquisitions.

ARCHBOLD, Ohio, Oct. 01, 2021 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (“F&M”, “FMAO”, or the “Company”) (Nasdaq: FMAO), the holding company for Farmers & Merchants State Bank, announced today that it has completed the acquisition of Perpetual Federal Savings Bank, Inc. (“PFSB”). Lars Eller, President and CEO of F&M, stated, “I am excited to close our third acquisition in the last 12 months. PFSB expands our presence within compelling Ohio markets including Urbana, Dayton, and Sidney, with significant potential for customer growth between Findlay and Urbana. We are excited to bring our relationship driven banking experience and wide range of financial services to PFSB customers. On behalf of everyone at the Company, we are pleased to welcome the customers and employees of PFSB to F&M.” F&M...

Farmers National Banc Corp. and Cortland Bancorp Announce Election Deadline of October 25, 2021

Written by Customer Service on October 1, 2021. Posted in Mergers And Acquisitions.

CANFIELD, Ohio, Oct. 01, 2021 (GLOBE NEWSWIRE) — Farmers National Banc Corp. (“Farmers”) (NASDAQ: FMNB), the holding company for The Farmers National Bank of Canfield, and Cortland Bancorp (“Cortland”) (NASDAQ: CLDB), the holding company for The Cortland Savings and Banking Company, today announced an election deadline of 5:00 p.m., Eastern Standard Time, October 25, 2021 (the “Election Deadline”) for shareholders of Cortland to elect the form of consideration they wish to receive for their shares of Cortland common stock in connection with the proposed merger of Cortland with and into FMNB Merger Subsidiary IV, LLC, a newly-formed, wholly-owned subsidiary of Farmers (“Merger Sub”), pursuant to the Agreement and Plan of Merger, dated as of June 22, 2021, by and among Farmers, Merger Sub and Cortland (the “Merger”). The Election...

United Community Banks, Inc. Announces Completion of Merger With Aquesta Financial Holdings, Inc. and Aquesta Bank

Written by Customer Service on October 1, 2021. Posted in Mergers And Acquisitions.

GREENVILLE, S.C., Oct. 01, 2021 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NASDAQ: UCBI) (United) has completed its merger, effective October 1, 2021, with Aquesta Financial Holdings, Inc. (OTC Pink: AQFH) (Aquesta), including its wholly-owned subsidiary, Aquesta Bank, which was merged into United’s bank subsidiary, United Community Bank. Aquesta will now operate under the United brand. Aquesta brings a premier franchise focused on providing personal service to business owners and individuals who care about their community. Their nine branches, located in Charlotte’s most attractive markets and also in the coastal city of Wilmington, North Carolina, will add to United’s high growth footprint. As of June 30, 2021, Aquesta reported total assets of $739 million and $641 million in deposits. Ninety-three percent of Aquesta’ s...

AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%

Written by Customer Service on October 1, 2021. Posted in Earnings Releases And Operating Results.

PHILADELPHIA, Oct. 01, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the six months ended June 30, 2021. Financial highlights:Total revenues were approximately RMB9.3 million (US$1.4 million) for the six months ended June 30, 2021, representing an increase of 128.5% from approximately RMB4.1 million for the six months ended June 30, 2020.Gross profit margin was approximately 61.4% for the six months ended June 30, 2021, representing an increase of 16.1 percentage points from approximately 45.3% for the six months ended June 30, 2020, primarily due to higher selling prices charged for cancer differentiation analysis (“CDA”)-based tests and...

G1 Therapeutics Announces Permanent J-Code from Centers for Medicare and Medicaid Services

Written by Customer Service on October 1, 2021. Posted in Public Companies.

Effective Today, New J-code to Streamline Reimbursement RESEARCH TRIANGLE PARK, North Carolina, Oct. 01, 2021 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the permanent J-code for COSELA™ (trilaciclib) that was issued in July 2021 by the Centers for Medicare & Medicaid Services (CMS) is now effective for provider billing for all sites of care. The permanent J-code for COSELA, J1448 (Injection, trilaciclib, 1mg.), published online on the CMS website here (page 5). J-codes are permanent, product specific reimbursement codes assigned to outpatient and physician administered “buy and bill” products under Medicare Part B and are used by commercial insurers and government payers to facilitate and standardize claims submissions and reimbursements for medications...

LexaGene Expands Brand Awareness at Key Investor Conferences

Written by Customer Service on October 1, 2021. Posted in Public Companies.

BEVERLY, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately two hours, today announced it will be featured at three investor relations conferences in early October. LexaGene management will also participate in one-on-one meetings at each conference. “Attending these conferences allows us to update current investors and introduce LexaGene as an investment opportunity to future investors,” said Dr. Jack Regan, LexaGene’s CEO and Founder. “The veterinary trade shows we attended in September made it clear that our technology is at the forefront of innovation and is expected to change the way diagnostics are performed in veterinary...

Tyler Van Buren Joins Cowen’s Equity Research Team to Cover Biotechnology

Written by Customer Service on October 1, 2021. Posted in Public Companies.

NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Tyler Van Buren has joined the Company’s equity research team to further expand the firm’s coverage of the biotechnology sector. He will be based in New York and will report to Robert Fagin, Cowen’s Head of Research. “We are delighted to welcome Tyler back to Cowen’s industry-leading health care research team,” said Mr. Fagin. “Our clients rely on Cowen’s premier biotechnology research to make informed investment decisions. We remain committed to expanding our research offerings and services.” Prior to joining Cowen, Mr. Van Buren was a Managing Director and senior biotechnology equity research analyst at Piper Sandler. Prior to Piper Sandler, Mr. Van Buren spent five years on the biopharma research team at Cowen....

Biofrontera reports preliminary approximate revenues for the month of September 2021

Written by Customer Service on October 1, 2021. Posted in Public Companies.

Leverkusen, Germany, Oct. 01, 2021 (GLOBE NEWSWIRE) — Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of September 2021. The Company’s preliminary, unaudited revenue from product sales in September 2021 was in the range of EUR 2.3 and 2.5 million, compared to EUR 1.8 million in September 2020, an increase of about 33%. Preliminary revenues from product sales in the US were between EUR 1.6 and 1.8 million compared to EUR 1.0 million in September 2020, an increase of about 64%. In Germany, revenues from product sales were in the range of EUR 0.4 and 0.6 million, compared to EUR 0.6 million in September 2020, a decline of about 19%. In the rest of Europe, the Company generated product sales of around...

WPD Pharmaceuticals Announces AGSM Results

Written by Customer Service on October 1, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Oct. 01, 2021 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, announces the results of its annual general and special meeting held September 29, 2021 in Vancouver, Canada. Re-elected as directors of the Company are Liam Lake Corcoran, Teresa Rzepczyk and Peter Novak. The Company’s option plan and appointment of auditors were approved. Because the Company has been exploring various avenues to better access much needed capital, another motion put forward by management was to vote to delist the Company’s shares from trading on the CSE (the “Delisting Resolutions”). The reasoning for the delisting was communicated by management in the Company’s news release dated September 2, 2021. In order to protect shareholders, the...

Day: October 1, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals